Epwin (EPWN); reports FY18 revenues decreased to £281.1m
Epwin reports it has also made substantial progress with the consolidation of Macclesfield’s extrusion operations
Epwin’s FY18 results for the year ending 31 December 2018 show revenue decreased year-on-year to £281.1m, down from £292.8m, mostly due to the planned closure of the Cardiff plant and the loss of the group’s largest two customers.
Read more...Walker Greenbank (WGB); reveals revenue up 1% to £113.3m for FY 2019
Walker Greenbank reports adjusted underlying PBT decreased 25.2%
Walker Greenbank posted its final-results for 2018 today. Statutory PBT and PAT were down by 51.4% and 57.1%, respectively. Adjusted underlying EPS fell 26.9% to 10.80p, while net debt stood at £0.4m. The total dividend of 3.24p (FY 2018: 4.37p) reflects the subsequent reduction in profits.
Read more...Destiny Pharma (DEST); reports on dermal infection clinical programme for XF-73
The FDA has also granted Fast Track designation for XF-73
Last year Destiny Pharma initiated a dermal infection clinical programme with its XF-73 anti-infective targeting diabetic foot ulcer infections. Phase 1 of this programme for the prevention of post-surgical infections has been successfully completed and the protocol for phase 2b, due to start in April 2019, has been finalised.
Read more...appScatter Group (APPS); acquire Airpush and issue £2.2m new shares
appScatter also announced a £2.2m subscription for new shares, at 26.8p per share
appScatter has proposed an acquisition of Airpush, a mobile ad network and mobile monetization company, which represents a reverse takeover under the AIM Rules. The issue of new shares in appScatter will fund the proposed acquisition. Existing appScatter and Airpush shareholders will account for 25% and 75% of the enlarged share capital, respectively.
Read more...Mission Marketing (TMMG); revenue increases 13% to £78.8m for FY18
Mission Marketing reports PBT at £11.0m compared to £5.8m in FY 2017
Mission Marketing announced results for the financial year ending Dec 2018. Headline operating margins improved to 12.6%, while headline PBT increased 22% to £9.5m. Diluted EPS was 10.63p and net debt reduced to £4.0m. The full-year dividend rose 24% to 2.1p.
Read more...Avacta Group (AVCT); H119 revenue down from £1.5m in FY18
The group is aiming to initiate first-in-human clinical studies for its Affimer drug platform in 2020
Avacta today reported that its operating loss increased from £4.5m in FY18 to £5.9m for the half year ended 31 January 2019, with an increase in R&D costs to £2.4m against £1.5m for FY18. Cash balance stood at £11.8m in H1, against £5.2m at the end of July 2018.
Read more...Stride Gaming (STR); report the board does not expect to recover H1 revenue shortfall through tra
Stride gaming expects to report a strong performance from Stride Together (a B2B joint venture)
Stride Gaming announced an update on its current trading. The Board expects to report net gaming revenue (NGR) for the six-month period ended 28 February 2019 approximately 5% lower than anticipated. According to the company, this reflects disruption arising from the fiscal and regulatory changes implemented in the second half of 2018.
Read more...Nanoco Group (NANO); report adjusted EBITDA loss narrows to £2.5m
The company also reported "substantial progress" in Life Sciences
Nanoco Group’s H119 results show a substantial improvement in revenue to £3.2m, from £0.2m in the first quarter of 2018. Adjusted EBITDA loss for the period reduced significantly to £2.5m from £4.2m for the same period last year. Billings during the period also increased substantially to £4.3m.
Read more...Circle Property (CRC); achieves 100% occupancy at Kents Hill Business Park
Under the terms of the lease, Grand Union Housing will acquire the entire first floor of the refurbished 40,000 sq ft
Circle Property reported that it has leased the remaining 21,150 sq ft of vacant space at its Kents Hill Park property, in Milton Keynes, to Grand Union Housing Group.
Read more...Chemring Group (CHG); sells its military trading business for $4m
For the year ended 31 October 2018, Chemring reported revenue of $111m and operating profit of $11m.
Chemring sold its military trading business, Chemring Military Products (CMP), for a cash consideration of $4m to Global Ordinance. Of the total consideration, $2.5m was paid on the sales completion. The remaining $1.0m and $0.5m will be paid on the first and second anniversaries of the initial sale, respectively.
Read more...